Andreas Lind

  • Research scientist MD, PhD
  • +47 221 18851
 

Publications 2018

Rachman L, Liuni M, Arias P, Lind A, Johansson P, Hall L, Richardson D, Watanabe K, Dubal S, Aucouturier JJ (2018)
DAVID: An open-source platform for real-time transformation of infra-segmental emotional cues in running speech
Behav Res Methods, 50 (1), 323-343
DOI 10.3758/s13428-017-0873-y, PubMed 28374144

Publications 2016

Lind A, Wängberg B, Ellegård L (2016)
Vitamin D and vitamin B12 deficiencies are common in patients with midgut carcinoid (SI-NET)
Eur J Clin Nutr, 70 (9), 990-4
DOI 10.1038/ejcn.2016.40, PubMed 27026421

Plicht B, Lind A, Erbel R (2016)
[Infective endocarditis : New ESC guidelines 2015]
Internist (Berl), 57 (7), 675-90
DOI 10.1007/s00108-016-0086-y, PubMed 27307162

Prebensen C, Lind A, Dyrhol-Riise AM, Kvale D (2016)
Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
PLoS One, 11 (4), e0153849
DOI 10.1371/journal.pone.0153849, PubMed 27128502

Publications 2015

Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D (2015)
High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
J Acquir Immune Defic Syndr, 69 (4), 395-402
DOI 10.1097/QAI.0000000000000617, PubMed 26115437

Publications 2014

Brekke K, Lind A, Holm-Hansen C, Haugen IL, Sørensen B, Sommerfelt M, Kvale D (2014)
Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial
PLoS One, 9 (11), e112556
DOI 10.1371/journal.pone.0112556, PubMed 25398137

Kran AMB, Lind A, Sommerfelt MM, Baksaas I, Sørensen B, Kvale D (2014)
Comparable Cellular Immune Responses in Patients with and without Antiretroviral Treatment after Immunization with HIV-1 P24, P17 and Tat Consensus Peptides (Vacc-5q)
J AIDS Clin Res, 5 (4), 1000294
DOI 10.4172/2155-6113.1000296, PublikaID 217

Lind A, Brekke K, Pettersen FO, Mollnes TE, Trøseid M, Kvale D (2014)
A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
PLoS One, 9 (1), e85604
DOI 10.1371/journal.pone.0085604, PubMed 24416431

Publications 2013

Lind A, Brekke K, Sommerfelt M, Holmberg JO, Aass HC, Baksaas I, Sørensen B, Dyrhol-Riise AM, Kvale D (2013)
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
Vaccine, 31 (41), 4611-8
DOI 10.1016/j.vaccine.2013.07.037, PubMed 23906886

Publications 2012

Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D (2012)
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
Scand J Infect Dis, 44 (8), 566-72
DOI 10.3109/00365548.2011.653581, PubMed 22339485

Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
Innate Immun, 19 (3), 290-7
DOI 10.1177/1753425912461042, PubMed 23070967

Publications 2011

Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
DOI 10.1128/JVI.00073-11, PubMed 21490090

Publications 2009

Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
J Clin Microbiol, 47 (7), 2170-4
DOI 10.1128/JCM.00519-09, PubMed 19420166

Page visits: 3086